In diffuse B-cell lymphoma (DLBCL), high FOXP3 expression was correlated with a poor prognosis in patients and when miR-155 was silenced in these cells, there was a parallel decrease in FOXP3 levels [59]. Here, FOXP3 is linked to diffuse large B-cell lymphoma.